AION Labs

We aim to transform drug discovery and development with groundbreaking #AI technology, contributing to the health and well-being of all people worldwide.

[Mati Gill @matigill]

“Building Tomorrow’s Cures”

As a proud #alumni, It was a special honor for me to meet the current Executive #MBA in #Healthcare and #Innovation of Reichman University and lead a session with great colleague about venture formation and trends for technology in #biotech and #digitalhealth

@GalNoyman1 @AshkenaziRenana @LionBirdVC @AionLabs @insitro @ISRLInnovation @ReichmanUni

[Mati Gill @matigill]

Love how that even on a Call Me Back / What’s your number podcast with @AnneNeuberger , a defense tech expert, when asked what technology she is most excited about she says without hesitance #AI in #pharma drug discovery and development

@YonatanAdiri @yaelwiss @dansenor @AionLabs

https://t.co/bcXmCZEuZv

[SynBioBeta @SynBioBeta]

Four pharma rivals, one AI sandbox. AION Labs brought together @pfizer, @AstraZeneca, @merckgroup, @Teva and @awscloud to test AI drug discovery bets on neutral ground. The model now has its first exit: https://t.co/XbjCYmvKQ1, acquired by @insitro for antibody optimization.

https://t.co/P3gj3BDlOX

Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬
https://t.co/SbgcHiS5fF

[Karin Hrovatin @KHrovatin]

ML for clinical trials requires thoughtful steering through the clinical landscape. We discussed what makes ML for clinical trials useful in practice with @RaulREsteban (Roche), Jessica Petrochuk and Adir Shaham (PhaseV), and Simon Romanski (Atlas Bio).
https://t.co/iit9xYNCm9

[Mati Gill @matigill]

להביא מדענים ישראלים חזרה ארצה ולבנות קהילה מדעית בישראל

אחת המשימות החשובות שלנו. לתעשיית הביוטק והייטק. ובכלל

כיף להיות שותפים עם ארגון @ScienceAbroad🇮🇱🧬💪🇮🇱

[Globes גלובס @globesnews]

"לא רציתי להיות יותר שכיר חרב": המנכ"ל שנפצע בגבול עזה ועשה שינוי
https://t.co/iofiGb0UGM

[Mati Gill @matigill]

Huge congratulations to our @AionLabs own and @WeizmannScience PhD candidate Yumi Minyi Yao for being selected to be in @Forbes 30 under 30!

https://t.co/0U439zM0P3

[Mati Gill @matigill]

תודה רבה @roy_katz על ההזדמנות לדבר על AI בפיתוח תרופות, על איך אנחנו מקימים חברו ב @AionLabs וההזדמנות של ישראל להיות מקור חדשנות לביוטק העולמי 🇮🇱💪🧬 @tv10israel

[Weizmann Institute @WeizmannScience]

Congratulations to Profs. Yifat Merbl of the Department of Systems Immunology and Schraga Schwartz of the Department of Molecular Genetics, upon being awarded the ERC Proof of Concept 2026 #ERCPoC
@ERC_Research
@YMerbl
@SchragaSchwartz

[Mati Gill @matigill]

@NucleateHQ Israel 🇮🇱 was founded just 4 years ago.

We were introduced to the #community by @liyamchitayat.

Since then, they have built a true national powerhouse for the #biotech industry in Israel 🇮🇱 with groups on all major Israeli Universities where cutting edge scientific research happens.
We at @AionLabs have been proud to partner with them from inception and watch them grow.

It was therefore very special for me to be invited to speak at their annual activator event, where I share the blueprint for how we can build the Israeli #Biotechnology #Ecosystem to be on of the top 10 in the world within 10 years. 💪🇮🇱🧬

Because if you have a clear vision, plan and great people to pull it off: “If you will it, It is no Dream”

[Mati Gill @matigill]

At @AionLabs we pride ourselves as being a learning organization. I make mistakes. We make mistakes, "we learn from what works. We learn from what doesn't work, especially, and try to not make the same mistake twice."

We're blessed with shareholders and partners that support this organizational culture.

This is one of the topics we discussed in part 3 of The #Biotech #Startups #Podcast I held with @jonchee_excedr of @ExcedrInc .

We also touched on:

🎙️ How the AION Labs partnership came together with our founding partners @pfizer @AstraZeneca @merckgroup @TevaUSA @awscloud and #ibf
🎙️ The #innovation model of #biomedx that we built on and adapted as our venture studio model
🎙️ The @ISRLInnovation #bioconvergence program
🎙️ The lessons learned from the first startup we had to shut down and the story behind the successful sale of our portfolio company https://t.co/XesbfaRUNz to @insitro

Apple Podcasts: https://t.co/zbulBfFwfS
Spotify: https://t.co/7c6NPrbsWZ
YouTube: https://t.co/b33qBPrpO8

#biotechnology #lifesciences #podcast

[Mati Gill @matigill]

סיכום מעולה של @galiw2 ב @globesnews לשיחה שקיימנו עם משקיעים מובילים מישראל 🇮🇱 ארה״ב 🇺🇸 ואירופה 🇪🇺 בכנס ביומד השנתי שניסינו לפענח את המיתוסים שסטארטאפים ישראלים נאחזים בהם, וסוגי החברות שמצליחים לגייס, ואלו שלא - וגם אלו חברות המשקיעים מרגישים ש״פספסו״
@ShaharTzafrir @Pitango @TLV_Partners @TriventuresVC @EntreeCap @AionLabs

https://t.co/bZz2meIldt

[Mati Gill @matigill]

Loved getting very personal in Part 1 of this conversation with @jonchee_excedr of @ExcedrInc on their #Biotech #Startups #podcast discussing:

🎙️ My rule of 3 for how to build a great family, pursue an ambitious career and impact our country and society Hint, its not about work-life balance, rather about focusing on what really matters.

🎙️ My core values that have remained very consistent and guided my career and life decisions since the age of 20

🎙️ How we moved to Israel 🇮🇱 from Ohio 🇺🇲

Hope you enjoy!

On Spotify: https://t.co/aQrsv5mQlu

On Apple: https://t.co/gGsbM6RBNS

@AionLabs

[Recursion @RecursionPharma]

One of the most important applications of AI is in improving clinical trials which encompass up to 70% of R&D costs and where most drugs in development fail.

On June 17, 4:20pm at @HLTHEVENT Europe in Amsterdam, Recursion CFO Ben Taylor will present on the panel “Trials & tribulations: Exploring the next frontier in evidence generation,” looking at the rise of new clinical models that are shifting the traditional framework – including in silico models, digital twins, synthetic controls, adaptive frameworks, and hybrid or decentralized trials.

He’ll be joined by Mati Gill, CEO of @AionLabs; Peter Donnelly, Co-Founder & CEO of Genomics; and Yajing Zhu, Director, Computational RWE at @novonordisk. Moderated by Adama Ibrahim, President, Digital Transformation at Crest Meridian, the panel will explore how clinical trials have evolved, expected breakthroughs on the horizon, and how pharma can prepare for a world where evidence generation is faster, more diverse, and increasingly augmented by technology.

👉 Learn more: https://t.co/egTYH26hlW

[Ohad Hammer @ohadhammer]

Biotech IPOs in 2025 and 2026 and how they performed so far (From Lifesci)

[Mati Gill @matigill]

Thank you @JamesSpiro for hosting me on the Spiro Circle to talk about the opportunities for Israel 🇮🇱 to be a future hub for global biotech innovation 💪🇮🇱🧬

[James Spiro @JamesSpiro]

Pharma has been looking for new sources of innovation for the industry globally.

Israel can play a role as "a central hub" due to its university research, AI leadership in tech, and capability to work across two scientific disciplines.

@AionLabs CEO @matigill explains >

[Weizmann Institute @WeizmannScience]

Congratulations to Prof. @jacob_hanna of the Department of Molecular Genetics, upon being awarded the 2026 Dahleh Lectureship and Award at UCSB

[Startup Nation Central @sncentral_]

Israel’s innovation ecosystem is once again operating under complex circumstances.

Escalation and uncertainty affect daily life, teams, families, and routines. And still, across the ecosystem, companies continue to build, serve global customers, raise capital, and create impact.

This is resilience in real time.
This is Israeli tech. Agile. Relentless.

Since October 7th, we have seen founders adjust operating models overnight, leadership teams prioritize employee wellbeing while maintaining performance, and investors reinforce their long-term commitment to Israeli innovation.

Israeli tech companies deliver. No Matter What.

Together with @ViolaGroup, G-CMO, and Atreo we launched the “No Matter What” page to document how companies sustain business continuity in challenging times, sharing practical insights and leadership lessons from across the field.

As we navigate another period of disruption, we invite founders and leaders across the ecosystem to share their experience.

-How have you adapted your operations?
-How are you supporting your teams during this time?
-What lessons or insights can help strengthen the broader Israeli tech community?

Startup Nation Central remains committed to supporting the ecosystem, connecting global partners to Israeli innovation and ensuring that even in uncertainty, opportunity continues to move forward.

Everything you need to share the message is available in one place.
Use the communications kit to communicate clearly, consistently, and confidently, including FAQs, key talking points, ready-to-use social posts, and customizable visuals.

Access it here - https://t.co/EQPE9NkrNQ

#NoMatterWhat #IsraeliTech #StartupNation

[AION Labs @AionLabs]

@sncentral_ We are proud to be partners and to take part